Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia
ClinicalTrials.gov study NCT00003619. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT01211457. IPD Sharing: NO. Countries: 1. Publications: 0.
Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02299518. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00488709. IPD Sharing: Not stated. Countries: 1. Publications: 18.
Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker
ClinicalTrials.gov study NCT07060001. IPD Sharing: YES. Countries: 1. Publications: 63.
A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04075747. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04716452. IPD Sharing: YES. Countries: 1. Publications: 3.
Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04230239. IPD Sharing: NO. Countries: 1. Publications: 14.
Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03881826. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive Chemotherapy
ClinicalTrials.gov study NCT00739388. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01132586. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission
ClinicalTrials.gov study NCT00150878. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00004056. IPD Sharing: Not stated. Countries: 2. Publications: 0.
An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
ClinicalTrials.gov study NCT05907057. IPD Sharing: YES. Countries: 4. Publications: 1.
Study Evaluating Sorafenib Added to Standard Primary Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Less Than 60 Years of Age
ClinicalTrials.gov study NCT00893373. IPD Sharing: NO. Countries: 1. Publications: 3.
Treatment of Older Adult Acute Myeloid Leukemia Patients Aged 55 to 65 Years
ClinicalTrials.gov study NCT02432872. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT05674539. IPD Sharing: NO. Countries: 1. Publications: 15.
Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00394381. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive Chemotherapy
ClinicalTrials.gov study NCT04454580. IPD Sharing: NO. Countries: 1. Publications: 4.
A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old
ClinicalTrials.gov study NCT00927498. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.